Repositorio Institucional
Repositorio Institucional
CONICET Digital
  • Inicio
  • EXPLORAR
    • AUTORES
    • DISCIPLINAS
    • COMUNIDADES
  • Estadísticas
  • Novedades
    • Noticias
    • Boletines
  • Ayuda
    • General
    • Datos de investigación
  • Acerca de
    • CONICET Digital
    • Equipo
    • Red Federal
  • Contacto
JavaScript is disabled for your browser. Some features of this site may not work without it.
  • INFORMACIÓN GENERAL
  • RESUMEN
  • ESTADISTICAS
 
Artículo

Induction of apoptosis in human pancreatic cancer stem cells by the endoplasmic reticulum-targeted alkylphospholipid analog edelfosine and potentiation by autophagy inhibition

Gajate, Consuelo; Gayet, Odile; Fraunhoffer Navarro, Nicolas AlejandroIcon ; Iovanna, Juan Lucio; Dusetti, Nelson; Mollinedo, Faustino
Fecha de publicación: 12/2021
Editorial: MDPI
Revista: Cancers
ISSN: 2072-6694
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:
Patología

Resumen

Pancreatic cancer is one of the most lethal malignancies with a poor and gloomy prognosis and the highest mortality-to-incidence ratio. Pancreatic cancer remains an incurable malignancy, and current therapies are ineffective. We isolated cancer stem cells (CSCs) from the human PANC-1 pancreatic cancer cell line as CD44+ CD24+ EpCAM+ cells. These CSCs form pancreatic cancer spheres or spheroids and develop tumors in SCID mice after subcutaneous injection of as few as 100 cells per mouse. Here, we found that the alkylphospholipid analog edelfosine inhibited CSC pancreatic cancer spheroid formation and induced cell death, as assessed by an increase in the percentage of cells in the sub-G0 /G1 region by means of flow cytometry, indicative of DNA breakdown and apoptosis. This correlated with an increase in caspase-3 activity and PARP breakdown, as a major substrate of caspase-3, following PANC-1 CSC treatment with edelfosine. The antitumor ether lipid edelfosine colocalized with the endoplasmic reticulum in both PANC-1 cells as well as PANC-1 CSCs by using a fluorescent edelfosine analog, and induced an endoplasmic reticulum stress response in both PANC-1 cells and PANC-1 CSCs, with a potent CHOP/GADD153 upregulation. Edelfosine elicited a strong autophagy response in both PANC-1 cells and PANC-1 CSCs, and preincubation of CSCs with autophagy inhibitors, chloroquine or bafilomycin A1, enhanced edelfosine-induced apoptosis. Primary cultures from pancreatic cancer patients were sensitive to edelfosine, as well as their respective isolated CSCs. Nontumorigenic pancreatic human cell line HPNE and normal human fibroblasts were largely spared. These data suggest that pancreatic CSCs isolated from established cell lines and pancreatic cancer patients are sensitive to edelfosine through its accumulation in the endoplasmic reticulum and induction of endoplasmic reticulum stress.
Palabras clave: ALKYLPHOSPHOLIPID ANALOG , ANTITUMOR ETHER LIPID , AUTOPHAGY , EDELFOSINE , ENDO-PLASMIC RETICULUM TARGETING , ENDOPLASMIC RETICULUM , PANCREATIC CANCER , PANCREATIC CANCER SPHEROID , PANCREATIC CANCER STEM CELL , PRIMARY CULTURES FROM PANCREATIC CANCER PATIENTS
Ver el registro completo
 
Archivos asociados
Thumbnail
 
Tamaño: 3.450Mb
Formato: PDF
.
Descargar
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution 2.5 Unported (CC BY 2.5)
Identificadores
URI: http://hdl.handle.net/11336/212641
DOI: http://dx.doi.org/10.3390/cancers13236124
Colecciones
Articulos(CEFYBO)
Articulos de CENTRO DE ESTUDIOS FARMACOLOGICOS Y BOTANICOS
Citación
Gajate, Consuelo; Gayet, Odile; Fraunhoffer Navarro, Nicolas Alejandro; Iovanna, Juan Lucio; Dusetti, Nelson; et al.; Induction of apoptosis in human pancreatic cancer stem cells by the endoplasmic reticulum-targeted alkylphospholipid analog edelfosine and potentiation by autophagy inhibition; MDPI; Cancers; 13; 23; 12-2021; 1-22
Compartir
Altmétricas
 

Items relacionados

Mostrando titulos relacionados por título, autor y tema.

  • Artículo Development of transcriptomic tools for predicting the response to individual drug of the mFOLFIRINOX regimen in patients with metastatic pancreatic cancer
    Fraunhoffer Navarro, Nicolas Alejandro ; Teyssedou, Carlos; Pessaux, Patrick; Bigonnet, Martin; Dusetti, Nelson; Iovanna, Juan (Frontiers Media, 2024-09)
  • Artículo Novel role of VMP1 as modifier of the pancreatic tumor cell response to chemotherapeutic drugs
    Gilabert, Mariana; Vaccaro, Maria Ines ; Fernandez Zapico, Martín E.; Calvo, Ezequiel L.; Turrini, Olivier; Secq, Véronique; Garcia, Stéphanie; Moutardier, Vincent; Lomberk, Gwen; Dusetti, Nelson; Urrutia, Raul; Iovanna, Juan L. (Wiley, 2013-09)
  • Artículo Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk
    Orozco, Carlos A.; Martinez Bosch, Neus; Guerrero, Pedro E.; Vinaixa, Judith; D'alotto Moreno, Tomas ; Iglesias, Mar; Moreno, Mireia; Djurec, Magdolna; Poirier, Françoise; Gabius, Hans Joachim; Fernandez Zapico, Martin Ernesto; Hwang, Rosa F.; Guerra, Carmen; Rabinovich, Gabriel Adrián ; Navarro, Pilar (National Academy of Sciences, 2018-04)
Enviar por e-mail
Separar cada destinatario (hasta 5) con punto y coma.
  • Facebook
  • X Conicet Digital
  • Instagram
  • YouTube
  • Sound Cloud
  • LinkedIn

Los contenidos del CONICET están licenciados bajo Creative Commons Reconocimiento 2.5 Argentina License

https://www.conicet.gov.ar/ - CONICET

Inicio

Explorar

  • Autores
  • Disciplinas
  • Comunidades

Estadísticas

Novedades

  • Noticias
  • Boletines

Ayuda

Acerca de

  • CONICET Digital
  • Equipo
  • Red Federal

Contacto

Godoy Cruz 2290 (C1425FQB) CABA – República Argentina – Tel: +5411 4899-5400 repositorio@conicet.gov.ar
TÉRMINOS Y CONDICIONES